Home
    Disclaimer
    L-Tryptophan molecular structure

    L-Tryptophan Stats & Data

    5-htp Oxyfan Telesol Triptum Levothym 5htp 5-hydroxytryptophan tryptophan
    NPS DataHub
    MW220.23
    FormulaC11H12N2O3
    CAS4350-09-8
    IUPAC(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid
    SMILESO=C([O-])C(N)Cc1cnc2ccc(O)cc12.[H+]
    InChIKeyLDCYZAJDBXYCGN-VIFPVBQESA-N
    Chemical Class medicine

    Pharmacology

    DrugBank
    State Solid Metabolism Hepatic.

    Description

    An essential amino acid that is necessary for normal growth in infants and for nitrogen balance in adults. It is a precursor of indole alkaloids in plants. It is a precursor of serotonin (hence its use as an antidepressant and sleep aid). It can be a precursor to niacin, albeit inefficiently, in mammals.

    Mechanism of Action

    A number of important side reactions occur during the catabolism of tryptophan on the pathway to acetoacetate. The first enzyme of the catabolic pathway is an iron porphyrin oxygenase that opens the indole ring. The latter enzyme is highly inducible, its concentration rising almost 10-fold on a diet high in tryptophan. Kynurenine is the first key branch point intermediate in the pathway. Kynurenine undergoes deamniation in a standard transamination reaction yielding kynurenic acid. Kynurenic acid and metabolites have been shown to act as antiexcitotoxics and anticonvulsives. A second side branch reaction produces anthranilic acid plus alanine. Another equivalent of alanine is produced further along the main catabolic pathway, and it is the production of these alanine residues that allows tryptophan to be classified among the glucogenic and ketogenic amino acids. The second important branch point converts kynurenine into 2-amino-3-carboxymuconic semialdehyde, which has two fates. The main flow of carbon elements from this intermediate is to glutarate. An important side reaction in liver is a transamination and several rearrangements to produce limited amounts of nicotinic acid, which leads to production of a small amount of NAD+ and NADP+.

    Pharmacodynamics

    Tryptophan is critical for the production of the body's proteins, enzymes and muscle tissue. It is also essential for the production of niacin, the synthesis of the neurotransmitter serotonin and melatonin. Tryptophan supplements can be used as natural relaxants to help relieve insomnia. Tryptophan can also reduce anxiety and depression and has been shown to reduce the intensity of migraine headaches. Other promising indications include the relief of chronic pain, reduction of impulsivity or mania and the treatment of obsessive or compulsive disorders. Tryptophan also appears to help the immune system and can reduce the risk of cardiac spasms. Tryptophan deficiencies may lead to coronary artery spasms. Tryptophan is used as an essential nutrient in infant formulas and intravenous feeding. Tryptophan is marketed as a prescription drug (Tryptan) for those who do not seem to respond well to conventional antidepressants. It may also be used to treat those afflicted with seasonal affective disorder (a winter-onset depression). Tryptopan serves as the precursor for the synthesis of serotonin (5-hydroxytryptamine, 5-HT) and melatonin (N-acetyl-5-methoxytryptamine).

    Toxicity

    Oral rat LD50: > 16 gm/kg. Investigated as a tumorigen, mutagen, reproductive effector. Symptoms of overdose include agitation, confusion, diarrhea, fever, overactive reflexes, poor coordination, restlessness, shivering, sweating, talking or acting with excitement you cannot control, trembling or shaking, twitching, and vomiting.

    Indication

    Tryptophan may be useful in increasing serotonin production, promoting healthy sleep, managing depression by enhancing mental and emotional well-being, managing pain tolerance, and managing weight.

    Effect Profile

    Curated + 101 Reports
    Opioid 3.9

    Strong itching/nausea and sedation with moderate euphoria

    Euphoria / Warmth×3
    66.1
    Analgesia×2
    0
    Sedation / Relaxation×1
    85.2
    Itching / Nausea×1
    96.7
    Catalog Erowid

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1d Half tolerance 21d Baseline ~35d

    Experience Report Analysis

    Erowid
    101 Reports
    2000–2025 Date Range
    39 With Age Data
    28 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 101 experience reports (101 Erowid)

    101 Reports
    28 Effects Detected
    12 Positive
    10 Adverse
    6 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 12

    Anxiety Suppression 38.6% 70%
    Stimulation 33.7% 70%
    Euphoria 32.7% 70%
    Sedation 32.7% 70%
    Tactile Enhancement 21.8% 70%
    Color Enhancement 19.8% 70%
    Empathy 19.8% 70%
    Music Enhancement 16.8% 70%
    Focus Enhancement 16.8% 70%
    Body High 9.9% 70%
    Introspection 8.9% 70%
    Creativity Enhancement 4.0% 70%

    Adverse Effects 10

    Nausea 29.7% 70%
    Confusion 19.8% 70%
    Sweating 11.9% 70%
    Headache 7.9% 70%
    Increased Heart Rate 7.9% 70%
    Memory Suppression 7.9% 70%
    Jaw Clenching 6.9% 70%
    Muscle Tension 5.9% 70%
    Motor Impairment 5.0% 70%
    Seizure 3.0% 70%

    Real-World Dose Distribution

    62K Doses

    From 59 individual dose entries

    Oral (n=54)

    Median: 125.0mg 25th: 100.0mg 75th: 287.5mg 90th: 500.0mg
    mg/kg median: 2.151 mg/kg 75th: 4.476

    Common Combinations

    Most co-occurring substances in experience reports

    Form / Preparation

    Most common forms and preparations reported

    Redose Patterns

    Redosing behavior across 12 reports

    8.3% Redosed
    1.1 Avg Doses
    ← Back to L-Tryptophan